Back to search

Switzerland· 58618006

ARTISS 2 ml, Lösung für Gewebekleber

A lokale hämostatika, kombinationen product containing fibrinogenum humanum, aprotininum syntheticum, thrombinum humanum, calcii chloridum dihydricum, registered in Switzerland by Baxter AG and dispensed under Swissmedic category B. The same ATC class is registered in 11 of our 19 countries.

Cat B (Swissmedic)ATC B02BC30

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedARTISS 2 ml, Lösung für GewebekleberATCB02BC30REGISTER NO.58618006PACKS LISTED0CHECKEDSeptember 12, 2026

Where it is registered

Lokale hämostatika, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BC30 (lokale hämostatika, kombinationen), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose

Lokale hämostatika, kombinationen · ATC B02BC30

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
fibrinogenum humanum, aprotininum syntheticum, thrombinum humanum, calcii chloridum dihydricum
Manufacturer
Baxter AG
Country
Switzerland (CH)
ATC code
B02BC30
ATC class
Lokale Hämostatika, Kombinationen
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3f869b65-0419-446f-a1a0-6d2a20c0a185
GET /v1/drugs/3f869b65-0419-446f-a1a0-6d2a20c0a185?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}

See everything about lokale hämostatika, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.